Cases & Deals

  • Home
  • Practices
  • Bora Pharmaceuticals acquires MacroGenics, Inc.'s GMP manufacturing operations

Share

Bora Pharmaceuticals acquires MacroGenics, Inc.'s GMP manufacturing operations

May 2026

Client(s) Bora Pharmaceuticals Co., Ltd.

Jones Day represented Bora Pharmaceuticals Co., Ltd. in its acquisition of the GMP manufacturing operations, including the CDMO business, of MacroGenics, Inc. (Nasdaq: MGNX) for $122.5 million cash.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.